Mary Vilakazi-led FirstRand flags extra UK provision risk
FirstRand warns of a possible extra UK provision as tensions rise with the Financial Conduct Authority.
Skip to content
FirstRand warns of a possible extra UK provision as tensions rise with the Financial Conduct Authority.
LLH Capital trims its holding in Optasia’s R6.5bn IPO and lines up a fresh push into AI and fintech across Africa.
Swazi billionaire Natie Kirsh’s fortune has fallen by $710 million to $9.69 billion as weaker asset valuations hit his global retail and real estate holdings.
Jonathan Oppenheimer urges South Africa to cut red tape and empower small businesses to drive growth.
South African tycoon Niall Lynch’s Motus stake rises above $31 million as shares climb 50% on renewed investor confidence and global expansion.
South African billionaire Patrice Motsepe’s ARM shuts Beeshoek mine after ArcelorMittal ends iron ore purchases.
Vodacom confirmed that its board approved the agreement on Nov. 4 and said the financial impact will be reflected in its half-year results due Nov. 10.
New GX Capital secures $43 million from Standard Bank to scale renewable power, storage, water and gas projects.
Angolan startup Anda, co-founded by entrepreneur Sergio Tati, raised €3 million ($3.5 million) to formalize and finance the country’s motorcycle taxis.
South African billionaire Johann Rupert’s fortune drops by $800 million as Richemont faces an EU antitrust fine and cooling luxury demand.
Pepkor, linked to Christo Wiese, completes $98.2 million acquisition of Retailability brands, expanding across Southern Africa.
South African entrepreneur Dr Iqbal Survé turned a tiny seed-capital investment into a sprawling holding company that spans media, technology, fishing, healthcare and events
Zimbabwean businessman Lovemore Kurotwi loses Supreme Court appeal over $3.6 million Canadile Miners funds.
Standard Bank secures JPMorgan approval in Angola, boosting cross-border trade access and expanding global reach.
Stephen Saad’s Aspen stake drops $18 million as shares fall 5.45% in 16 days, deepening losses for South Africa’s largest drugmaker.
Stephen Saad’s Aspen wins $29 million settlement in mRNA production dispute, boosting investor confidence after a tough fiscal year.